We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Lupin Pharmaceuticals

News List

Lupin Pharmaceuticals Issues Voluntary Recall of Ceftriaxone for Injection americanpharmaceuticalreview
January 10, 2019
Lupin Pharmaceuticals is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection .....
Lupin scouts for acquisitions across the world biospectrumasia
November 16, 2018
Leading Indian drugmaker Lupin Pharmaceuticals is looking at US, China and Japan for company and brand acquisitions in an effort to grow globally
Lupin Pharmaceuticals recalls 12,888 bottles of ulcer drug in US expressbpd
September 15, 2017
Drug firm Lupin’s US arm, Lupin Pharmaceuticals, is recalling 12,888 bottles of Famotidine for oral suspension used in treatment of ulcers from the American market.